Revenue for QQ4 2024: $579,214, down YoY by 19.76% but up QoQ by 104.02% from Q3 2024. Gross profit: $17,157; gross margin: 2.96% (0.0296). Operating income: -$733,776; operating margin: -1.27%. Net income: -$729,078; net margin: -1.26%. EBITDA: -$729,078; EBITDARatio: -1.26. Earnings per share (diluted): -$0.022. Weighted average shares outstanding: 33,213,306.
Liquidity and cash flow: Cash and cash equivalents: $986,427. Net cash provided by operating activities: -$27,535. Free cash flow: -$27,535. Net change in cash: -$27,535. Cash at end of period: $986,427. No long-term debt reported. Inventories: $1,787,308; accounts receivable: $1,805,980; other current assets: $76,815. Total current assets: $4,656,530. Total current liabilities: $61,100. Retained earnings: -$20,742,538. Shareholders’ equity totals are plagued by data inconsistencies in the provided set, but net cash position is clearly positive and the company carries no reported debt.
Key efficiency indicators (rounded): DSO ~280.6 days, DIO ~286.2 days, CCC ~566.8 days, cash conversion cycle remains elevated due to working capital structure. Price-to-sales ~35.09x, price-to-book ~4.42x, enterprise value multiple ~-26.53x (reflecting cash-rich balance with no debt). These imply a market valuation that does not yet reflect scalable profitability or meaningful cash generation from operations.